The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Sep. 26, 2004
Tove Ringerike, Oslo, NO;
Robert Jan Vandehriel, Bilthoven, NL;
Aurelia Walczak-drzewiecka, Lodz, PL;
Khalid Al-nedawi, Lodz, PL;
Janina Wyczolkowska, Lodz, PL;
Maciej Stepnik, Lodz, PL;
Joanna Arkusz, Lodz, PL;
Konrad Rydzynski, Lodz, PL;
Violetta Adamczewska, Warsaw, PL;
Dominka Trzaska, Warsaw, PL;
Maciej Olszewski, Warsaw, PL;
Urszula Bialek-wyrzykowska, Warsaw, PL;
Jaroslaw Dastych, Warsaw, PL;
Martinus Lovik, Oslo, NO;
Nilsson Gunnar, Uppsala, SE;
Ulleras Erik, Uppsala, SE;
Tove Ringerike, Oslo, NO;
Robert Jan Vandehriel, Bilthoven, NL;
Aurelia Walczak-Drzewiecka, Lodz, PL;
Khalid Al-Nedawi, Lodz, PL;
Janina Wyczolkowska, Lodz, PL;
Maciej Stepnik, Lodz, PL;
Joanna Arkusz, Lodz, PL;
Konrad Rydzynski, Lodz, PL;
Violetta Adamczewska, Warsaw, PL;
Dominka Trzaska, Warsaw, PL;
Maciej Olszewski, Warsaw, PL;
Urszula Bialek-Wyrzykowska, Warsaw, PL;
Jaroslaw Dastych, Warsaw, PL;
Martinus Lovik, Oslo, NO;
Nilsson Gunnar, Uppsala, SE;
Ulleras Erik, Uppsala, SE;
National Institute of Public Health and the Environment, Laboratory For Pathology and Immunobiology, Bilthoven, NL;
Norwegian Institute of Public Health, Division of Environmental Medicine, Oslo, NO;
Nofer Institute of Ocupational Medicine and Who/Collaborating Centre, Lodz, PL;
Department of Biogenic Amines, Polish Academy of Sciences, Lodz, PL;
International Institute of Molecular And Cell Biology In Warsaw, Warsaw, PL;
Abstract
A method is described for the characterization of a tested substance, particularly useful in the study of its toxicity, and in particular immunotoxicity. Also described are cell lines and nucleic acids useful in its procurement, which may be used to embody said method, particularly in obtaining cell-chip collections destined for immunotoxicity assays.